nilla, Author at European Medical Journal - Page 8 of 20

How to enhance value and access across pharma

In this episode, the GOLD team shares a conversation with Christoph Glaetzer, Chief Global Value and Access Officer, Johnson & Johnson.

Inspiring innovation and the future of digital therapeutics

Helena and Jade introduce a discussion on the future of digital therapeutics with Eugene Borukhovich, Co-Founder and COO, YourCoach.Health.

Pharma insights from the team behind GOLD

Listen to the GOLD team: Helena, Isabel and Jade will discuss key articles, themes and insights from the latest issue of GOLD.

Driving confidence and participation in genetic research

In this episode, Helena and Isabel are joined by Patrick Short, CEO, Sano Genetics, to discuss the challenges and opportunities facing genetic medicine.

Meet GOLD's next catalyst – Reshema Kemps-Polanco

Helena and Isabel speak to GOLD catalyst interviewee Reshema Kemps-Polanco, Executive Vice President and US Head, Novartis Oncology.

Unpicking pharma’s reputation in pop culture

Helena is joined by Paul Simms, CEO, Impatient Health, to delve deeper into GOLD’s cover feature on reframing pharma’s bad boy reputation.

In conversation with GSK's Rino Rappuoli

This week, Helena and Isabel are honoured to be joined by Rino Rappuoli, Head of External R&D and Chief Scientist at GSK Vaccines.

Top tips for digital innovation and the future of patient centricity

Helena is joined by well-known pharma conference speaker Konrad Dobschuetz to discuss his top tips for digital innovation in the pharma industry.

Medical affairs, commercial and enhancing soft skills

In this episode, Helena hosts a medical affairs discussion with Novartis UK’s Samin Saeed about leadership, company culture, soft skills development and much more.

Pharmacovigilance past, present and future

Marc and Helena are joined by Pav Rishiraj, Director and Head of Pharmacovigilance, Ipsen, to shed light on this often-overlooked field.